Recombinant multi-species COLEC11 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine COLEC11 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the collectin family of C-type lectins that possess collagen-like sequences and carbohydrate recognition domains. Collectins are secreted proteins that play important roles in the innate immune system by binding to carbohydrate antigens on microorganisms, facilitating their recognition and removal. The encoded protein binds to multiple sugars with a preference for fucose and mannose. Mutations in this gene are a cause of 3MC syndrome-2. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
The Alternative Names of target: 3MC2,CL-11,CL-K1,CL-K1-I,CL-K1-II,CL-K1-IIa,CL-K1-IIb,CLK1,COLEC11,Colec11,Collectin kidney protein 1 (CL-K1),Collectin-11
Go
to COLEC11 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE0808-Ag-1/ GM-Tg-hg-SE0808-Ag-2 | Human COLEC11 protein | Human |
| GM-Tg-rg-SE0808-Ag-1/ GM-Tg-rg-SE0808-Ag-2 | Rat COLEC11 protein | Rat |
| GM-Tg-mg-SE0808-Ag-1/ GM-Tg-mg-SE0808-Ag-2 | Mouse COLEC11 protein | Mouse |
| GM-Tg-cynog-SE0808-Ag-1/ GM-Tg-cynog-SE0808-Ag-2 | Cynomolgus/Rhesus macaque COLEC11 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE0808-Ag-1/ GM-Tg-felg-SE0808-Ag-2 | Feline COLEC11 protein | Feline |
| GM-Tg-cang-SE0808-Ag-1/ GM-Tg-cang-SE0808-Ag-2 | Canine COLEC11 protein | Canine |
| GM-Tg-bovg-SE0808-Ag-1/ GM-Tg-bovg-SE0808-Ag-2 | Bovine COLEC11 protein | Bovine |
| GM-Tg-equg-SE0808-Ag-1/ GM-Tg-equg-SE0808-Ag-2 | Equine COLEC11 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE0808-Ag-1/ GM-Tg-hg-SE0808-Ag-2;
GM-Tg-rg-SE0808-Ag-1/ GM-Tg-rg-SE0808-Ag-2;
GM-Tg-mg-SE0808-Ag-1/ GM-Tg-mg-SE0808-Ag-2; GM-Tg-cynog-SE0808-Ag-1/ GM-Tg-cynog-SE0808-Ag-2; GM-Tg-felg-SE0808-Ag-1/ GM-Tg-felg-SE0808-Ag-2; GM-Tg-cang-SE0808-Ag-1/ GM-Tg-cang-SE0808-Ag-2; GM-Tg-bovg-SE0808-Ag-1/ GM-Tg-bovg-SE0808-Ag-2; GM-Tg-equg-SE0808-Ag-1/ GM-Tg-equg-SE0808-Ag-2 |
| Products Name | COLEC11 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | COLEC11 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine COLEC11 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.